Adult hospitalized patients with cystic fibrosis commonly receive nebulized medications. For single-patient-use nebulizers that are cleaned after each use, there is infrequent nebulizer contamination (0%-11%) with only low numbers of epidemiologically important pathogens (less than 100 colony-forming units), and this contamination is similar after 24, 48, and 72 hours of use.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1086/678603 | DOI Listing |
Ann Am Thorac Soc
July 2015
1 Department of Medicine, McMaster University, Hamilton, Ontario, Canada; and.
Rationale: The American Thoracic Society guidelines for methacholine testing for the diagnosis of asthma recommends the 2-minute tidal breathing protocol with the Wright nebulizer, which produces more aerosol than required, generates a small particle size, and requires cleaning between tests.
Objectives: To evaluate methacholine testing using a disposable, breath-actuated AeroEclipse II, which produces aerosol during inspiration and was developed for single-patient use.
Methods: Forty-six adult subjects with asthma (19 men), aged 27.
Infect Control Hosp Epidemiol
December 2014
Department of Hospital Epidemiology, University of North Carolina (UNC) Health Care, Chapel Hill, North Carolina.
Adult hospitalized patients with cystic fibrosis commonly receive nebulized medications. For single-patient-use nebulizers that are cleaned after each use, there is infrequent nebulizer contamination (0%-11%) with only low numbers of epidemiologically important pathogens (less than 100 colony-forming units), and this contamination is similar after 24, 48, and 72 hours of use.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!